🔗 Share this article

A shadow economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Removal

Based on the social media company, the platform has removed violative material and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.

After moments of entering one community, a seller posted contact information, where most transactions occur. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Product Details and Pricing

Within these communities, messages display black plastic parcels with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her team has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to possibly serious health risks”.